A Nonprofit Drug Development Model Is Part of the Antimicrobial Resistance (AMR) Solution

Antibiotics underpin modern medicine and are critical for pandemic preparedness. Push funding has revitalized the preclinical antimicrobial resistance (AMR) pipeline and government funding via CARB-X and BARDA, as well as private sector–led investment via the AMR Action Fund, will help several new a...

Descripción completa

Detalles Bibliográficos
Autores principales: Piddock, Laura J V, Paccaud, Jean-Pierre, O’Brien, Seamus, Childs, Michelle, Malpani, Rohit, Balasegaram, Manica
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Viewpoints
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9155596/
https://www.ncbi.nlm.nih.gov/pubmed/34618892
http://dx.doi.org/10.1093/cid/ciab887

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9155596/
https://www.ncbi.nlm.nih.gov/pubmed/34618892
http://dx.doi.org/10.1093/cid/ciab887

Ejemplares similares